Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of depletion of RNH1 on gene expression in KYSE510 cell

ABSTRACT: Accumulation of R-loops causes DNA breaks and genome instability, as well as regulates tumorigenesis in a mechanism that remains poorly understood. We knockdown the ribonuclease RNase H1 (RNH1) to generate a cell model of induced R-loop accumulation. We showed that the expression of a large number of genes was disturbed after RNH1 knockdown, including 961 genes with more than twofold differences . The KEGG pathway indicates that the target genes are enriched in the Hippo signaling pathway, Wnt signaling pathway, and other tumor-associated biological processes .

ORGANISM(S): Homo sapiens

PROVIDER: GSE275269 | GEO | 2025/08/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient E9.5 yolksac

Project description:Ribonuclease Inhibitor (RI also known as Rnh1) is a 50 kDa, ubiquitously expressed leucine-rich repeat (LRR) protein. It is localized in cytosol and binds to pancreatic-type ribonucleases and inhibit their function. However the entire biological role for Rnh1 is unknown. We generated Rnh1 knock out mice by homologous recombination. Here we studied differential gene expression from wild type (Rnh1 +/+), Heterozygous (Rnh1+/-) and Knock out (Rnh1-/-) yolk sacs isolated from embryonic day 9.5 (E9.5). We used microarrays to study global gene expression regulated by Rnh1 in yolk sacs. Total RNA was isolated from E9.5 yolk sacs of Rnh1 Wild type, heterozygous and knock out.

2013-07-01 | E-GEOD-48146 | biostudies-arrayexpress

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

Project description:Summary: Ribonuclease Inhibitor (RI also known as Rnh1) is a 50 kDa, ubiquitously expressed leucine-rich repeat (LRR) protein. It is localized in cytosol and binds to pancreatic-type ribonucleases and inhibit their function. However, the entire biological role for Rnh1 is unknown. We generated RNH1 knock out K562 cells by CRISPR/Cas9 method. Here we studied differential gene expression from wild type and RNH1 knock out K562 cells by RNA-Seq analysis. Overall design: Total RNA was isolated from wild type and RNH1 deficient K562 cells.

2017-03-05 | E-MTAB-5162 | biostudies-arrayexpress

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient E9.5 yolksac

2013-07-01 | GSE48146 | GEO

Regulation of mRNA translation by RNH1 in hematopoietic cells

Project description:Ribonuclease Inhibitor (RI also known as Rnh1) is a 50 kDa, ubiquitously expressed leucine-rich repeat (LRR) containing protein. It binds to pancreatic-type ribonucleases and inhibit their function. However, the entire biological role of Rnh1 is unknown. We generated RNH1 knock out K562 cells by CRISPR/Cas9 method. We isolated polysomal RNA from control and RNH1-deficient K562 cells to quantify actively translated mRNAs by RNA-seq.

2024-03-20 | GSE237169 | GEO

RNH1 in HSCs

Project description:Role of Ribonuclease inhibitor (RNH1) in haematopoietic stem cell function

| PRJEB35613 | ENA

Mus musculus

Project description:Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient E9.5 yolksac

| PRJNA208999 | ENA

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

Project description:Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

| PRJEB19635 | ENA

Proteomics of tumor and serum samples from isocitrate dehydrogenase-wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?

Project description:Proteomics has been little used for the identification of novel prognostic and/or therapeutic markers in isocitrate dehydrogenase (IDH)-wildtype glioblastoma (GB). In this study, we analyzed 50 tumor and 30 serum samples from short- and long-term survivors of IDH-wildtype GB (STS and LTS, respectively) by data-independent acquisition mass spectrometry (DIA-MS)-based proteomics, with the aim of identifying such markers. DIA-MS identified 5422 and 826 normalized proteins in tumor and serum samples, respectively, with only three tumor proteins and 26 serum proteins displaying significant differential expression between the STS and LTS groups. These dysregulated proteins were principally associated with the detoxification of reactive oxygen species (ROS). In particular, GB patients in the STS group had high serum levels of malate dehydrogenase 1 (MDH1) and ribonuclease inhibitor 1 (RNH1) and low tumor levels of fatty acid-binding protein 7 (FABP7), which may have enabled them to maintain low ROS levels, counteracting the effects of the first-line treament with radiotherapy plus concomitant and adjuvant temozolomide. A blood score built on the levels of MDH1 and RNH1 expression was found to be an independent prognostic factor for survival based on the serum proteome data for a cohort of 96 IDH-wildtype GB patients. This study highlights the utility of circulating MDH1 and RNH1 biomarkers for determining the prognosis of patients with IDH-wildtype GB. Furthermore, the pathways driven by these biomarkers, and the tumor FABP7 pathway, may constitute promising therapeutic targets for blocking ROS detoxification to overcome resistance to chemoradiotherapy in potential GB STS.

2024-07-04 | PXD045714 | Pride

Effect of depletion of RNH1 on gene expression in KYSE510 cell

Project description:Effect of depletion of RNH1 on gene expression in KYSE510 cell

| PRJNA1150151 | ENA

E-MTAB-5162

Project description:Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

2025-01-23 | E-MTAB-5162 | ExpressionAtlas